Dr. Syed Shams ul Hassan

Address:

School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China

Academic Metrics

• h-index: 31 
• i10-index: 65 
• Total Citations: 3,061

Research Interests:

• Marine Biotechnology
• Natural Product Discovery
• Medicinal Chemistry
• Anti-inflammatory & Anti-cancer Therapeutics
• Antimicrobial Resistance (AMR)
• Computational Drug Design & Molecular Docking
• Marine Microorganisms & Fungi
• Phytomedicine

Biography:

Dr. Syed Shams ul Hassan is a highly dedicated researcher specializing in the discovery and purification of natural products, primarily sourced from marine organisms. His core scientific focus involves investigating the anti-inflammatory and anti-cancer potential of these bioactive compounds. Utilizing a multidisciplinary approach, Dr. Hassan integrates advanced techniques such as stress induction, genomics, and sophisticated computational drug discovery methods, including molecular docking, to isolate novel therapeutics and unlock the pharmacological promise of marine microbial treasures. His work aims to combat global health challenges, particularly the urgent need for new antimicrobial and oncological agents.​

Education Details

• Ph.D. (Pharmaceutical Sciences/Natural Products), School of Pharmacy, Shanghai Jiao Tong University, China (2018–2022)
• Masters in Sciences (Marine Sciences), Ocean College, Zhejiang University, China (2014–2017)
• Bachelors (Doctor of Pharmacy, Pharm.D.), Faculty of Pharmacy, Gomal University, Pakistan (2007–2012)

Professional Background

• Faculty Member (Current), School of Pharmacy, Shanghai Jiao Tong University, Shanghai, China
• Post-Doctoral Researcher, Shanghai Jiao Tong University, Shanghai, China
• Associate Faculty, Chinese Academy of Sciences (CAS), Beijing, China

Achievements

• Best Graduate Award from Zhejiang University.
• Recipient of the Fully Funded Master's and Ph.D. Scholarship from the China Scholarship Council.
• Awarded the High Talent of the City award by the Government of Zhoushan city, Zhejiang, China (2019).

Current Research Projects

Dr. Hassan's current research focuses on the isolation, structural elucidation, and pharmacological evaluation of secondary metabolites from marine microorganisms (actinobacteria and fungi). Key projects include:

• Discovery of next-generation antibiotics by harnessing marine bacteria and utilizing metal-stress techniques.
• Computational drug discovery (chemoinformatics, molecular docking) to identify novel PBP2a-targeted antibiotics.
• Evaluating natural products for their therapeutic potential against chronic diseases, including Alzheimer's, osteoporosis, and various cancers.

Academic Profiles of Dr. Syed Shams ul Hassan

• Google Scholar
• ResearchGate
• Frontiers Loop Profile

Publications:

Dr. Hassan maintains a prolific publication record focusing on the translational research of marine and microbial natural products. His recent work highlights the potential of these compounds in addressing antimicrobial resistance and developing novel anti-cancer agents.
 

• Hassan, S. S. u., Ahmad, N., Rehman, A., Pan, C., Wu, J., Li, T., Yan, S., & Jin, H. (2025). A Cinderella story in antimicrobials: CDPDP's perfect fit for multiple-pathway bacterial inhibition. European Journal of Medicinal Chemistry. Published on 18 Jul 2025. DOI: 10.1016/j.ejmech.2025.117967
• Wu, J., Cao, Z., Ou, C., Wang, L., Ji, Y., Ma, M., Hassan, S. S. u., & Jin, H. (2025). A novel triterpenoid saponin from Pimpinella candolleana alleviates postmenopausal osteoporosis via P38/JNK MAPK-mediated osteogenesis. Phytomedicine. Published on 26 Jun 2025.
• Pan, C., Hassan, S. S. u., Ishaq, M., Yan, S., & Jin, H. (2025). Marine Actinomycetes: A Hidden Treasure Trove for Antibacterial Discovery. Frontiers in Marine Science. Published on 13 Feb 2025.
• Pan, C., Hassan, S. S. u., Muhammad, I., & Jin, H. (2025). Marine Fungi as a Goldmine for Novel Antibiotics: A 2024 Perspective. Frontiers in Marine Science. Published on 21 Jan 2025.
• Hassan, S. S. u., & Jin, H. (2025). Harnessing marine bacteria for next-gen antibiotics: potent inhibition of S. aureus and Riemerella anatipestifer through in vitro, omics, and chemoinformatics approach with enhanced production of secondary metabolites through zinc sulfate. Published on 06 Jan 2025.

 

Last Updated on September 30, 2025